Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Come True Biomedical

1997 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
6236 STOCK SYMBOL
1 INVESTMENTS
$0.29 SHARE PRICE (As of Tuesday Closing)
Description

Come True Biomedical Inc operates as a biotechnology company in Taiwan. It is involved in the following business divisions such as biotechnology, medical cosmetics, and preventive medicine businesses.

Formerly Known As
Topro Technology
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Application Specific Semiconductors
Stock Exchange
ROCO
Primary Office
  • 19th Floor,No. 17 Chengde Road, Section 1
  • Tatung District
  • Taipei, 103-51
  • Taiwan

+886 02 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Come True Biomedical’s full profile, request a free trial.

Come True Biomedical Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.21 - $0.83 $9.1M $0.31 -$0.04 5.8K 31.7M

Come True Biomedical Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 8,660 24,007 24,279 20,850
Revenue 2,898 3,227 5,616 3,904
EBITDA (997) (1,505) (1,373) (385)
Net Income (1,359) (2,076) (1,780) (879)
Total Assets 5,801 6,028 9,702 8,737
Total Debt 1,485 1,354 2,230 2,053
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Come True Biomedical Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000000 24-Jun-2015 000000000000000000 00.000 Distributors (Healthcare)
To view this company’s complete investment and acquisition history, request access »